同时爆发的黑色细胞和由恩科拉费尼布诱导的多重角瘤
Nektarios Alevizopoulos1, Dimitrios Alexandris2, Michail G Pavlakis3
1Oncology, Evangelismos General Hospital, Athens, GRC.
Cureus
|October 31, 2024
概括
治疗BRAF抑制剂恩科拉费尼布可能会导致罕见的皮肤疾病,如喷发性瘤和角瘤. 停止使用BRAF抑制剂可能会解决这些不良皮肤事件.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在治疗转移性结直肠癌方面,BRAF抑制剂至关重要.
- 皮肤不良事件在BRAF抑制剂中很常见,但同时爆发性内和角瘤是罕见的.
- 线素激活蛋白激酶 (MAPK) 途径与这些皮肤毒性有关.
相关概念视频
Skin Cancer
3.8K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.8K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K


